OneSource Specialty Pharma Limited (BOM:544292)
India
· Delayed Price · Currency is INR 1,881.00
-14.40 (-0.76%)
At close: Aug 14, 2025
BOM:544292 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
| Revenue | 14,798 | 14,449 | 1,719 | 387.14 |
| Revenue Growth (YoY) | 760.77% | 740.43% | 344.07% | - |
| Cost of Revenue | 4,293 | 4,350 | 852.13 | 336.43 |
| Gross Profit | 10,506 | 10,098 | 867.06 | 50.71 |
| Selling, General & Admin | 2,208 | 2,153 | 825.5 | 749.29 |
| Other Operating Expenses | 3,390 | 3,280 | 844.61 | 808.7 |
| Operating Expenses | 8,332 | 8,172 | 2,433 | 2,215 |
| Operating Income | 2,174 | 1,926 | -1,566 | -2,164 |
| Interest Expense | -1,518 | -1,663 | -853.99 | -401.06 |
| Interest & Investment Income | - | - | 17.65 | 14.67 |
| Currency Exchange Gain (Loss) | - | - | -5.75 | -91.59 |
| Other Non Operating Income (Expenses) | 187.5 | 174.74 | -38.97 | -73.21 |
| EBT Excluding Unusual Items | 843.66 | 437.79 | -2,447 | -2,715 |
| Merger & Restructuring Charges | -1,108 | -1,108 | - | - |
| Gain (Loss) on Sale of Investments | - | - | 7.57 | 1.15 |
| Gain (Loss) on Sale of Assets | - | - | -58.08 | - |
| Asset Writedown | - | - | -1,159 | -1,451 |
| Pretax Income | -248.49 | -670.66 | -3,657 | -4,156 |
| Income Tax Expense | -129.29 | -497.85 | - | - |
| Earnings From Continuing Operations | -119.2 | -172.81 | -3,657 | -4,156 |
| Earnings From Discontinued Operations | -6.9 | -6.9 | -254.68 | -3,842 |
| Net Income | -126.1 | -179.71 | -3,912 | -7,998 |
| Net Income to Common | -126.1 | -179.71 | -3,912 | -7,998 |
| Shares Outstanding (Basic) | 106 | 110 | 42 | 40 |
| Shares Outstanding (Diluted) | 106 | 110 | 42 | 40 |
| Shares Change (YoY) | 155.88% | 165.37% | 4.34% | - |
| EPS (Basic) | -1.19 | -1.63 | -94.15 | -200.87 |
| EPS (Diluted) | -1.19 | -1.63 | -94.15 | -200.87 |
| Free Cash Flow | - | -1,960 | -1,710 | -2,068 |
| Free Cash Flow Per Share | - | -17.78 | -41.15 | -51.93 |
| Gross Margin | 70.99% | 69.89% | 50.43% | 13.10% |
| Operating Margin | 14.69% | 13.33% | -91.09% | -558.99% |
| Profit Margin | -0.85% | -1.24% | -227.53% | -2066.00% |
| Free Cash Flow Margin | - | -13.57% | -99.45% | -534.07% |
| EBITDA | 5,407 | 4,665 | -803.03 | -1,507 |
| EBITDA Margin | 36.54% | 32.29% | -46.71% | - |
| D&A For EBITDA | 3,233 | 2,739 | 762.95 | 656.8 |
| EBIT | 2,174 | 1,926 | -1,566 | -2,164 |
| EBIT Margin | 14.69% | 13.33% | -91.09% | - |
| Revenue as Reported | 14,986 | 14,623 | 1,761 | 414.06 |
| Advertising Expenses | - | - | 5.04 | 10.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.